Ajinomoto Bio-Pharma (AJINOMOTO ALTHEA INC.)

History

YearDetail
2018 Ajinomoto Althea and OmniChem collaborated their capabilities to form Ajinomoto Bio-Pharma Services, a fully integrated company in the U.S. and Belgium.
2019 GeneDesign Inc., a wholly owned subsidiary of Ajinomoto, joined Ajinomoto Bio-Pharma Services to strengthen its commitment to its customers and become a leading global contract development and manufacturing organization (CDMO) with comprehensive capabilities.
2020 Ajinomoto Bio-Pharma Services acquired Granules OmniChem Pvt. Ltd., a joint venture in India. The addition of Ajinomoto Bio-Pharma Services India Pvt. Ltd. will strengthen Aji Bio-Pharma's commitment to offering its clients access to a reliable and simplified CDMO supply chain worldwide.